BrightPath Biotherapeutics

Works in Cardiovascular · Hematology · Immunology · Oncology · Respiratory

BrightPath Biotherapeutics is a clinical trial sponsor. It has 1 active clinical trial with 18 planned participants, across 5 therapeutic areas. Since 2021 it has completed 0 trials and stopped 1 early.

Trial track record · since 2021

1Active trials18 planned participants
0Completed0 with results posted
1Stopped earlyterminated, withdrawn or suspended

Pipeline · 1 active trial

StageTrialStatus

Questions about BrightPath Biotherapeutics

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-21.

Approve Suite is not affiliated with BrightPath Biotherapeutics.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.